Cargando…
Infective endocarditis involving MitraClip(©) devices: a systematic literature review
PURPOSE: Progress of interventional cardiology has boosted the use of newer cardiac devices. These devices are perceived to be less prone to infections compared to traditional surgical prostheses, but little data are currently available. In this systematic review (SR), we summarize current literatur...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545607/ https://www.ncbi.nlm.nih.gov/pubmed/37386329 http://dx.doi.org/10.1007/s15010-023-02067-y |
_version_ | 1785114704361816064 |
---|---|
author | Bertolino, Lorenzo Ramadan, Mohammad Said Zampino, Rosa Durante-Mangoni, Emanuele |
author_facet | Bertolino, Lorenzo Ramadan, Mohammad Said Zampino, Rosa Durante-Mangoni, Emanuele |
author_sort | Bertolino, Lorenzo |
collection | PubMed |
description | PURPOSE: Progress of interventional cardiology has boosted the use of newer cardiac devices. These devices are perceived to be less prone to infections compared to traditional surgical prostheses, but little data are currently available. In this systematic review (SR), we summarize current literature regarding the clinical characteristics, management, and outcomes of patients with MitraClip-related infective endocarditis (IE). METHODS: We conducted a SR of PubMed, Google Scholar, Embase, and Scopus between January 2003 and March 2022. MitraClip-related IE was defined according to 2015 ESC criteria whereas MitraClip involvement as vegetation on the device or on the mitral valve. Risk of bias was assessed through standardized checklist and potential bias of underestimation cannot be excluded. Data regarding clinical presentation, echocardiography, management, and outcome were collected. RESULTS: Twenty-six cases of MitraClip-related IE were retrieved. The median age of patients was 76 [61–83] years with a median EuroScore of 41%. Fever was present in 65.8% of patients followed by signs and symptoms of heart failure (42.3%). IE occurred early in 20 (76.9%) cases with a median time between MitraClip implantation and IE symptom onset of 5 [2–16] months. Staphylococcus aureus was the major causative microorganism (46%). Surgical mitral valve replacement was needed in 50% of patients. A conservative medical approach was considered in the remainder. The overall in-hospital mortality rate was 50% (surgical group: 38.4%; medical group: 58.3%; p = 0.433). CONCLUSION: Our results suggest that MitraClip-related IE affects elderly, comorbid patients, is mostly due to Staphylococcus aureus, and has a poor prognosis irrespective of the therapeutic approach. Clinicians must be aware of the features of this new entity among cardiovascular infections. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-023-02067-y. |
format | Online Article Text |
id | pubmed-10545607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105456072023-10-04 Infective endocarditis involving MitraClip(©) devices: a systematic literature review Bertolino, Lorenzo Ramadan, Mohammad Said Zampino, Rosa Durante-Mangoni, Emanuele Infection Review PURPOSE: Progress of interventional cardiology has boosted the use of newer cardiac devices. These devices are perceived to be less prone to infections compared to traditional surgical prostheses, but little data are currently available. In this systematic review (SR), we summarize current literature regarding the clinical characteristics, management, and outcomes of patients with MitraClip-related infective endocarditis (IE). METHODS: We conducted a SR of PubMed, Google Scholar, Embase, and Scopus between January 2003 and March 2022. MitraClip-related IE was defined according to 2015 ESC criteria whereas MitraClip involvement as vegetation on the device or on the mitral valve. Risk of bias was assessed through standardized checklist and potential bias of underestimation cannot be excluded. Data regarding clinical presentation, echocardiography, management, and outcome were collected. RESULTS: Twenty-six cases of MitraClip-related IE were retrieved. The median age of patients was 76 [61–83] years with a median EuroScore of 41%. Fever was present in 65.8% of patients followed by signs and symptoms of heart failure (42.3%). IE occurred early in 20 (76.9%) cases with a median time between MitraClip implantation and IE symptom onset of 5 [2–16] months. Staphylococcus aureus was the major causative microorganism (46%). Surgical mitral valve replacement was needed in 50% of patients. A conservative medical approach was considered in the remainder. The overall in-hospital mortality rate was 50% (surgical group: 38.4%; medical group: 58.3%; p = 0.433). CONCLUSION: Our results suggest that MitraClip-related IE affects elderly, comorbid patients, is mostly due to Staphylococcus aureus, and has a poor prognosis irrespective of the therapeutic approach. Clinicians must be aware of the features of this new entity among cardiovascular infections. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-023-02067-y. Springer Berlin Heidelberg 2023-06-29 2023 /pmc/articles/PMC10545607/ /pubmed/37386329 http://dx.doi.org/10.1007/s15010-023-02067-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Bertolino, Lorenzo Ramadan, Mohammad Said Zampino, Rosa Durante-Mangoni, Emanuele Infective endocarditis involving MitraClip(©) devices: a systematic literature review |
title | Infective endocarditis involving MitraClip(©) devices: a systematic literature review |
title_full | Infective endocarditis involving MitraClip(©) devices: a systematic literature review |
title_fullStr | Infective endocarditis involving MitraClip(©) devices: a systematic literature review |
title_full_unstemmed | Infective endocarditis involving MitraClip(©) devices: a systematic literature review |
title_short | Infective endocarditis involving MitraClip(©) devices: a systematic literature review |
title_sort | infective endocarditis involving mitraclip(©) devices: a systematic literature review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545607/ https://www.ncbi.nlm.nih.gov/pubmed/37386329 http://dx.doi.org/10.1007/s15010-023-02067-y |
work_keys_str_mv | AT bertolinolorenzo infectiveendocarditisinvolvingmitraclipdevicesasystematicliteraturereview AT ramadanmohammadsaid infectiveendocarditisinvolvingmitraclipdevicesasystematicliteraturereview AT zampinorosa infectiveendocarditisinvolvingmitraclipdevicesasystematicliteraturereview AT durantemangoniemanuele infectiveendocarditisinvolvingmitraclipdevicesasystematicliteraturereview |